These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8758902)

  • 1. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
    Joseph IB; Vukanovic J; Isaacs JT
    Cancer Res; 1996 Aug; 56(15):3404-8. PubMed ID: 8758902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
    Vukanovic J; Isaacs JT
    Cancer Res; 1995 Apr; 55(7):1499-504. PubMed ID: 7533663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J; Isaacs JT
    Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
    Vukanovic J; Passaniti A; Hirata T; Traystman RJ; Hartley-Asp B; Isaacs JT
    Cancer Res; 1993 Apr; 53(8):1833-7. PubMed ID: 7682157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
    Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
    Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    Isaacs JT; Pili R; Qian DZ; Dalrymple SL; Garrison JB; Kyprianou N; Björk A; Olsson A; Leanderson T
    Prostate; 2006 Dec; 66(16):1768-78. PubMed ID: 16955399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.
    Joseph IB; Isaacs JT
    Prostate; 1996 Sep; 29(3):183-90. PubMed ID: 8827087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
    Lucia MS; Anzano MA; Slayter MV; Anver MR; Green DM; Shrader MW; Logsdon DL; Driver CL; Brown CC; Peer CW
    Cancer Res; 1995 Dec; 55(23):5621-7. PubMed ID: 7585644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of linomide on advanced prostate-seminal vesicle cancers in Lobund-Wistar rats.
    Pollard M
    Prostate; 1998 Apr; 35(1):43-9. PubMed ID: 9537598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.
    Vukanovic J; Hartley-Asp B; Isaacs JT
    Prostate; 1995 May; 26(5):235-46. PubMed ID: 7538663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.
    Slayter MV; Anzano MA; Kadomatsu K; Smith JM; Sporn MB
    Cancer Res; 1994 Mar; 54(6):1440-5. PubMed ID: 8137245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
    Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P; Torres Filho IP; Hartley-Asp B
    Anticancer Res; 1995; 15(3):719-28. PubMed ID: 7544090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice.
    Gross DJ; Reibstein I; Weiss L; Slavin S; Stein I; Neeman M; Abramovitch R; Benjamin LE
    Clin Cancer Res; 1999 Nov; 5(11):3669-75. PubMed ID: 10589785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
    Yang Y; Ge JP; Zhou ZT
    J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.